Envoy Medical (COCH) Competitors

$0.66 -0.02 (-3.26%)

Closing price 05/13/2026 04:00 PM Eastern

Extended Trading

$0.66 0.00 (-0.27%)

As of 04:21 AM Eastern

COCH vs. VANI, INFU, INGN, KRMD, and CVRX

Should you buy Envoy Medical stock or one of its competitors? MarketBeat compares Envoy Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envoy Medical include Vivani Medical (VANI), InfuSystem (INFU), Inogen (INGN), KORU Medical Systems (KRMD), and CVRx (CVRX). These companies are all part of the "medical equipment" industry.

How does Envoy Medical compare to Vivani Medical?

Envoy Medical (NASDAQ:COCH) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

Envoy Medical presently has a consensus target price of $6.00, indicating a potential upside of 812.13%. Vivani Medical has a consensus target price of $3.50, indicating a potential upside of 201.72%. Given Envoy Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Envoy Medical is more favorable than Vivani Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 7.1% of Envoy Medical shares are owned by company insiders. Comparatively, 53.3% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Envoy Medical has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.35, meaning that its stock price is 135% more volatile than the broader market.

In the previous week, Vivani Medical had 2 more articles in the media than Envoy Medical. MarketBeat recorded 4 mentions for Vivani Medical and 2 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.22 beat Vivani Medical's score of 0.93 indicating that Envoy Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Envoy Medical	Positive
Vivani Medical	Positive

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
Vivani Medical	N/A	-317.03%	-82.64%

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240K	210.72	-$23.76M	-$1.22	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.43	N/A

Summary

Envoy Medical beats Vivani Medical on 9 of the 15 factors compared between the two stocks.

How does Envoy Medical compare to InfuSystem?

Envoy Medical (NASDAQ:COCH) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

In the previous week, InfuSystem had 10 more articles in the media than Envoy Medical. MarketBeat recorded 12 mentions for InfuSystem and 2 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.22 beat InfuSystem's score of 0.66 indicating that Envoy Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Envoy Medical	Positive
InfuSystem	Positive

InfuSystem has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240K	210.72	-$23.76M	-$1.22	N/A
InfuSystem	$142.40M	1.16	$870K	$0.38	21.61

InfuSystem has a net margin of 1.12% compared to Envoy Medical's net margin of -9,875.64%. InfuSystem's return on equity of 2.78% beat Envoy Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
InfuSystem	1.12%	2.78%	1.41%

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 71.1% of InfuSystem shares are owned by institutional investors. 7.1% of Envoy Medical shares are owned by company insiders. Comparatively, 10.8% of InfuSystem shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Envoy Medical has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, InfuSystem has a beta of 1.49, meaning that its stock price is 49% more volatile than the broader market.

Envoy Medical presently has a consensus target price of $6.00, indicating a potential upside of 812.13%. InfuSystem has a consensus target price of $15.00, indicating a potential upside of 82.70%. Given Envoy Medical's higher probable upside, equities research analysts clearly believe Envoy Medical is more favorable than InfuSystem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

InfuSystem beats Envoy Medical on 11 of the 15 factors compared between the two stocks.

How does Envoy Medical compare to Inogen?

Inogen (NASDAQ:INGN) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations.

89.9% of Inogen shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 2.5% of Inogen shares are held by insiders. Comparatively, 7.1% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Inogen had 10 more articles in the media than Envoy Medical. MarketBeat recorded 12 mentions for Inogen and 2 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.22 beat Inogen's score of -0.14 indicating that Envoy Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Inogen	Neutral
Envoy Medical	Positive

Inogen has higher revenue and earnings than Envoy Medical. Inogen is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$348.67M	0.53	-$22.75M	-$0.91	N/A
Envoy Medical	$240K	210.72	-$23.76M	-$1.22	N/A

Inogen currently has a consensus price target of $13.00, indicating a potential upside of 90.90%. Envoy Medical has a consensus price target of $6.00, indicating a potential upside of 812.13%. Given Envoy Medical's higher probable upside, analysts plainly believe Envoy Medical is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Inogen has a net margin of -7.08% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-7.08%	-12.90%	-8.27%
Envoy Medical	-9,875.64%	N/A	-177.92%

Inogen has a beta of 1.64, meaning that its share price is 64% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.92, meaning that its share price is 92% more volatile than the broader market.

Summary

Inogen beats Envoy Medical on 9 of the 17 factors compared between the two stocks.

How does Envoy Medical compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 7.1% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, KORU Medical Systems had 2 more articles in the media than Envoy Medical. MarketBeat recorded 4 mentions for KORU Medical Systems and 2 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.22 beat KORU Medical Systems' score of 0.29 indicating that Envoy Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
KORU Medical Systems	Neutral
Envoy Medical	Positive

KORU Medical Systems has higher revenue and earnings than Envoy Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	4.30	-$2.64M	-$0.05	N/A
Envoy Medical	$240K	210.72	-$23.76M	-$1.22	N/A

KORU Medical Systems presently has a consensus price target of $7.25, indicating a potential upside of 88.31%. Envoy Medical has a consensus price target of $6.00, indicating a potential upside of 812.13%. Given Envoy Medical's higher probable upside, analysts clearly believe Envoy Medical is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

KORU Medical Systems has a net margin of -5.27% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Envoy Medical	-9,875.64%	N/A	-177.92%

KORU Medical Systems has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.92, indicating that its share price is 92% more volatile than the broader market.

Summary

KORU Medical Systems beats Envoy Medical on 10 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to CVRx?

Envoy Medical (NASDAQ:COCH) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

In the previous week, CVRx had 11 more articles in the media than Envoy Medical. MarketBeat recorded 13 mentions for CVRx and 2 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.22 beat CVRx's score of 0.42 indicating that Envoy Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Envoy Medical	Positive
CVRx	Neutral

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 7.1% of Envoy Medical shares are held by company insiders. Comparatively, 13.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

CVRx has a net margin of -89.14% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
CVRx	-89.14%	-108.72%	-47.06%

Envoy Medical currently has a consensus price target of $6.00, indicating a potential upside of 812.13%. CVRx has a consensus price target of $11.50, indicating a potential upside of 120.31%. Given Envoy Medical's higher possible upside, equities analysts plainly believe Envoy Medical is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

Envoy Medical has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, CVRx has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

Envoy Medical has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240K	210.72	-$23.76M	-$1.22	N/A
CVRx	$56.65M	2.44	-$53.31M	-$2.02	N/A

Summary

Envoy Medical beats CVRx on 9 of the 17 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COCH vs. The Competition

Export

Metric	Envoy Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$52.28M	$6.90B	$6.30B	$12.20B
Dividend Yield	N/A	1.72%	2.79%	5.30%
P/E Ratio	-0.65	49.93	21.00	25.58
Price / Sales	210.72	39.66	554.55	78.84
Price / Cash	N/A	24.21	42.94	55.34
Price / Book	5.06	6.49	9.75	6.66
Net Income	-$23.76M	$158.34M	$3.55B	$333.63M
7 Day Performance	-0.33%	-1.83%	-0.53%	-0.11%
1 Month Performance	-1.14%	-1.10%	1.20%	3.94%
1 Year Performance	-61.31%	-2.35%	41.22%	36.07%

Envoy Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COCH Envoy Medical	2.2095 of 5 stars	$0.66 -3.3%	$6.00 +812.1%	-59.4%	$52.28M	$240K	N/A	34	Earnings Report Gap Down
VANI Vivani Medical	3.698 of 5 stars	$1.27 +1.2%	$3.50 +176.7%	+10.5%	$109.09M	N/A	N/A	20	News Coverage Earnings Report
INFU InfuSystem	4.3823 of 5 stars	$10.25 -3.4%	$15.00 +46.3%	+42.8%	$207.01M	$143.44M	170.88	410
INGN Inogen	2.5445 of 5 stars	$7.11 +0.8%	$11.00 +54.8%	+10.9%	$194.18M	$348.67M	N/A	1,030	Earnings Report
KRMD KORU Medical Systems	3.257 of 5 stars	$4.05 -0.8%	$6.50 +60.6%	+19.9%	$187.84M	$41.13M	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COCH) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envoy Medical (COCH) Competitors

COCH vs. VANI, INFU, INGN, KRMD, and CVRX

How does Envoy Medical compare to Vivani Medical?

Summary

How does Envoy Medical compare to InfuSystem?

Summary

How does Envoy Medical compare to Inogen?

Summary

How does Envoy Medical compare to KORU Medical Systems?

Summary

How does Envoy Medical compare to CVRx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envoy Medical (COCH) Competitors

COCH vs. VANI, INFU, INGN, KRMD, and CVRX

How does Envoy Medical compare to Vivani Medical?

Do analysts recommend COCH or VANI?

Do institutionals and insiders believe in COCH or VANI?

Which has more risk and volatility, COCH or VANI?

Does the media refer more to COCH or VANI?

Is COCH or VANI more profitable?

Which has preferable earnings & valuation, COCH or VANI?

Summary

How does Envoy Medical compare to InfuSystem?

Does the media refer more to COCH or INFU?

Which has preferable earnings & valuation, COCH or INFU?

Is COCH or INFU more profitable?

Do institutionals and insiders believe in COCH or INFU?

Which has more risk and volatility, COCH or INFU?

Do analysts recommend COCH or INFU?

Summary

How does Envoy Medical compare to Inogen?

Do institutionals & insiders have more ownership in INGN or COCH?

Does the media favor INGN or COCH?

Which has better valuation and earnings, INGN or COCH?

Do analysts rate INGN or COCH?

Is INGN or COCH more profitable?

Which has more volatility & risk, INGN or COCH?

Summary

How does Envoy Medical compare to KORU Medical Systems?

Do insiders and institutionals believe in KRMD or COCH?

Does the media prefer KRMD or COCH?

Which has higher valuation and earnings, KRMD or COCH?

Do analysts prefer KRMD or COCH?

Is KRMD or COCH more profitable?

Which has more risk and volatility, KRMD or COCH?

Summary

How does Envoy Medical compare to CVRx?

Does the media refer more to COCH or CVRX?

Do institutionals and insiders have more ownership in COCH or CVRX?

Is COCH or CVRX more profitable?

Do analysts recommend COCH or CVRX?

Which has more volatility and risk, COCH or CVRX?

Which has better earnings & valuation, COCH or CVRX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools